COVID-19 Total Solution

 

DiaCarta offers a COVID-19 total solution to support the fight against COVID-19, including the RT-PCR test, antibody IgG test and CLIA lab service.

 

GET a quote

QuantiVirus™ SARS-CoV-2 Test Kit (RT-PCR Test - Detects 3 genes)

QuantiVirus™ SARS-CoV-2 Multiplex Test Kit (RT-PCR Test - Detects 1 gene)

QuantiVirus™ Anti-SARS-CoV-2 IgG Test Kit (Antibody Test) - Research Use Only

COVID-19 Clinical Laboratory Testing Service

Our Latest Press Releases for COVID-19 Total Solution

Press Release

DiaCarta Receives CE/IVD for its New COVID 19 Test that Identifies Delta Plus and New Variants

August 12, 2021  I  DiaCarta, Inc.

Press Release

DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants

April 22, 2021  I  DiaCarta, Inc.

Press Release

FDA Report: DiaCarta COVID-19 Tests Rank Top 3 Among FDA SARS-CoV-2 Reference Panel Tests

September 21, 2020  I  DiaCarta, Inc.

Press Release

DiaCarta’s COVID-19 Test Ranks Top 10 Among All FDA EUA Tests Based on Limit of Detection

September 2, 2020  I  DiaCarta, Inc.

Press Release

DiaCarta Receives Regulatory COFEPRIS Approval in Mexico & ICMR Approval in India for its FDA EUA Approved QuantiVirus™ SARS-CoV-2 Test

July 15, 2020  I  DiaCarta, Inc.

Press Release

DiaCarta SARS-CoV-2 Test Detecting 3 Viral Genes Receives US FDA Emergency Use Authorization & Test Manufacturing Expanded to 500K COVID-19 Tests/Week

April 13, 2020  I  DiaCarta, Inc.

Press Release

DiaCarta Inc. has filed for EUA with the FDA and has received CE mark for its highly sensitive QuantiVirus™ SARS-CoV-2 Test Kit

March 25, 2020  I  DiaCarta, Inc.

X